Men treated for nonmetastatic prostate cancer under current guidelines are up to 6 times less likely to die from their cancer than from other causes, according to data from a Swedish cancer registry.

New research in JNCCN—Journal of the National Comprehensive Cancer Network finds that for people diagnosed with nonmetastatic low-risk prostate cancer later in life, and treated according to NCCN ...

New research in the July 2025 issue of JNCCN-Journal of the National Comprehensive Cancer Network finds that for people diagnosed with nonmetastatic low-risk prostate cancer later in life, and treated ...

Former President Joe Biden’s advanced prostate cancer diagnosis has generated several estimates of how long he could live ― and some suggest his cancer could have cut short his term in office had he ...

Patients with nonmetastatic prostate cancer treated according to NCCN Guidelines are more likely to die of other natural causes than from their cancer. Patients with nonmetastatic prostate cancer who ...

Former U.S. President Joe Biden has been diagnosed with stage 4 metastatic prostate cancer, which has spread to his bones. Treatment for this type of prostate cancer can stall tumor growth, but at ...

Former President Joe Biden and other older men may not be getting routine prostate cancer screenings but his recent Stage 4 diagnosis raises questions about whether that's always the best choice.

PLYMOUTH MEETING, PA [July 10, 2025] — New research in the July 2025 issue of JNCCN—Journal of the National Comprehensive Cancer Network finds that for people diagnosed with nonmetastatic low-risk ...